MetaCap

Serina Therapeutics Statistics

NYSE: SERHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.12-0.08 (-6.67%)

At close: Nov 20, 3:59 PM ET · Delayed 15 min

Serina Therapeutics by the numbers

Serina Therapeutics has a market capitalization of $29.8 million based on 26.57M shares outstanding. With trailing EPS of $-1.63, Serina Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.4% below its 50-day average and 43.6% below its 200-day average.

Average daily trading volume is 68.98K shares, or about $77,262 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SER valuation vs. peer median

SER compared with the median of 8 peer companies
MetricSERPeer medianDifference
Market cap$29.76M$29.10M+2%
Avg. volume68.98K153.03K-55%

Peer median across 8 companies: NXTC, NNVC, RNTX, ATHE, AYTU, PMN, FLNA, GRDX.

Valuation

Market cap
$29.76M
Price / sales (latest FY)
228.91
EPS (TTM)
$-1.63

Price and trading

Previous close
1.20
Open
1.16
Day range
1.06 – 1.26
52-week range
1.06 – 4.26
52-week change
-71.93%
Beta
—
Volume
62.15K

Dividends and events

Annual dividend
None
Next earnings date
Nov 26, 2026

Additional statistics

Market Cap
29.76M
Forward Pe
-1.07
Eps
-1.63
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.26
Week52 Low
1.06
Avg Volume
68,984.00
Shares Outstanding
26.57M
Ma50
1.82
Ma200
1.98
Earnings Date
Nov 26, 2026
Pct From52w High
-73.71%
Pct From52w Low
5.66%

Related